Her2 and estrogen activate Src and inactivate p27 in breast cancer

被引：0
|
作者：
不详
机构：
来源：
CANCER BIOLOGY & THERAPY | 2007年 / 6卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] p27 regulation by estrogen and Src signaling in human breast cancer
    Slingerland, Joyce
    HORMONAL CONTROL OF CELL CYCLE, 2008, : 89 - 97
  • [2] Correlation of p27 protein expression with HER-2/neu expression in breast cancer
    Newman, L
    Xia, WY
    Yang, HY
    Sahin, A
    Bondy, M
    Lukmanji, F
    Hung, MC
    Lee, MH
    MOLECULAR CARCINOGENESIS, 2001, 30 (03) : 169 - 175
  • [3] The Predictive and Prognostic Significance of PTEN, P27 and PI3K Expression in HER2 Overexpressing Metastatic Breast Cancer
    Okutur, K.
    Bassulu, N.
    Aydin, K.
    Bozkurt, M.
    Namal, E.
    Tecimer, C.
    Mandel, N. M.
    Akcali, Z.
    Dogusoy, G. B.
    Demir, G.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S355 - S355
  • [4] Simultaneous targeting of estrogen receptor and HER2 in breast cancer
    Azim, Hatem A., Jr.
    Piccart, Martine J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (08) : 1255 - 1263
  • [5] Relationship between p53 and p27 expression following HER2 signaling
    Casalini, Patrizia
    Iorio, Marilena V.
    Berno, Valeria
    Bergamaschi, Anna
    Dale, Anne-Lise Borresen
    Gasparini, Patrizia
    Orlandi, Rosaria
    Casati, Barbara
    Tagliabue, Elda
    Menard, Sylvie
    BREAST, 2007, 16 (06): : 597 - 605
  • [6] Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 Abundance
    Emde, Anna
    Mahlknecht, Georg
    Maslak, Kerstin
    Ribba, Benjamin
    Sela, Michael
    Possinger, Kurt
    Yarden, Yosef
    TRANSLATIONAL ONCOLOGY, 2011, 4 (05): : 293 - 300
  • [7] HER2 Activating Mutations in Estrogen Receptor Positive Breast Cancer
    Murray E.M.
    Cherian M.A.
    Ma C.X.
    Bose R.
    Current Breast Cancer Reports, 2018, 10 (2) : 41 - 47
  • [8] Modulating therapeutic effects of c-Src inhibitor via estrogen receptor and HER2 in breast cancer cell lines
    Fan, Ping
    McDaniel, Russell E.
    Kim, Helen R.
    Jordan, V. Craig
    CANCER RESEARCH, 2012, 72
  • [9] Mechanistic insights into the misregulation of p27 in HER2-positive breast cancers
    Faltermeier, Claire M.
    Eide, Erik E.
    Roberts, James M.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [10] Is there an association between estrogen receptor and Her2/neu status in breast cancer?
    Hanna, W
    Kahn, HJ
    Szalai, JP
    MODERN PATHOLOGY, 2002, 15 (01) : 36A - 36A
12345